X

Clinical Trials

Contact Us

A191901 ***ACCRUAL FOR NON-BLACK WOMEN < 50 YEARS OLD WILL CLOSE 4/15/22*** ***ACCRUAL FOR NON-BLACK WOMEN ≥ 50 YEARS OLD WILL CLOSE 02/25/2022 **

Study Number: A191901 ***ACCRUAL FOR NON-BLACK WOMEN < 50 YEARS OLD WILL CLOSE 4/15/22*** ***ACCRUAL FOR NON-BLACK WOMEN ≥ 50 YEARS OLD WILL CLOSE 02/25/2022 **
Please Note:

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.

Available Sites
  • Missouri Baptist Medical Center
  • Missouri Baptist Outpatient Center – Sunset Hills
  • Missouri Baptist Sullivan Hospital
  • Sainte Genevieve County Memorial Hospital
  • Parkland Health Center - Farmington
Contact Person(s)
  • Monica Russo 314-996-5868

View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.